Copy Link Print Information

Sotuletinib dihydrochloride

(Synonyms: BLZ945 dihydrochloride)
42 Cited Publications
Customer Review

Based on 42 publication(s) in Google Scholar

Sotuletinib (BLZ945) dihydrochloride is a potent, selective, orally active and brain-penetrant CSF-1R (c-Fms) inhibitor with an IC50 of 1 nM, showing more than 1,000-fold selectivity against its closest receptor tyrosine kinase homologs. Sotuletinib dihydrochloride can be used for microglia depletion, and for tumor and CNS-related disease research.

For research use only. We do not sell to patients.

  • CAS No.: 2222138-40-9
  • Formula: C20H24Cl2N4O3S
  • Molecular Weight:471.40
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Sotuletinib dihydrochloride Chemical Structure
    Sotuletinib dihydrochloride Chemical Structure
  • Experimental Validation Results for Sotuletinib dihydrochloride
  • Experimental Validation Results for Sotuletinib dihydrochloride
  • Experimental Validation Results for Sotuletinib dihydrochloride
  • Experimental Validation Results for Sotuletinib dihydrochloride
  • Experimental Validation Results for Sotuletinib dihydrochloride
  • Experimental Validation Results for Sotuletinib dihydrochloride
CAS No.: 2222138-40-9
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Sotuletinib dihydrochloride:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Sotuletinib dihydrochloride

More
Customer Validation & Images
In Vivo Efficacy StudyIHCCell Proliferation/Viability AssayApoptosis AnalysisHistological Imaging/Staining
  • Cell Proliferation/Viability Assay
  • IHC
  • Apoptosis Analysis
  • In Vivo Efficacy Study
  • In Vivo Efficacy Study
  • Histological Imaging/Staining
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Sotuletinib dihydrochloride Chemical Structure
    Sotuletinib dihydrochloride Chemical Structure
    1/16
  • 1/16

    Sotuletinib dihydrochloride purchased from MedChemExpress. Usage Cited in: Mol Ther. 2025 Nov 12:S1525-0016(25)00871-8. [Abstract]

    Customer Validation
     Survival curves of WT (black) and G793A (blue) BM macrophages treated for seven days with BLZ945 (Sotuletinib, 0.1-10000 nM).

  • 1/16

    Sotuletinib dihydrochloride purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Dec;11(45):e2404756. [Abstract]

    Customer Validation
     Sotuletinib (BLZ945) (200 mg/kg; oral gavage; four times a week for 7 weeks) inhibited the infiltration of F4/80+ macrophages and reduced the expression of the M2 macrophage marker CD206 in DEN-CCl4-induced hepatocellular carcinoma-forming C57BL/6J mice.

  • 1/16

    Sotuletinib dihydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Med. 2023 Mar 6;220(3):e20220857. [Abstract]

    Customer Validation
     Quantification of iMG cell death by fluorescent Caspase 3/7 Dye for Apoptosis over 24 h in culture with complete medium treated with BLZ945 (Sotuletinib, 250 nM, 500 nM, or 1 µM; 5-20 h).

  • 1/16

    Sotuletinib dihydrochloride purchased from MedChemExpress. Usage Cited in: Bioact Mater. 2022 Mar 11:16:107-119. [Abstract]

    Customer Validation
     Prophylactic nanovaccine have a synergistic effect with BLZ-945 (Sotuletinib, 1 mg/kg; i.t.) and NLG-919 (2 mg/kg; i.t.), which inhibits tumor growth and prolongs survival in tumor-bearing mice.

  • 1/16

    Sotuletinib dihydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Med. 2016 Dec 12;213(13):2989-3005. [Abstract]

    Customer Validation
     Graph of percent tumor growth over baseline for 21 d of treatment with or without 200 mg/kg of BLZ945 (Sotuletinib, oral gavage; once daily). *, P < 0.05; **, P < 0.01. n = 5 per group, Student’s t test.

  • 1/16

    Sotuletinib dihydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Med. 2016 Dec 12;213(13):2989-3005. [Abstract]

    Customer Validation
     Examples of photomicrographs of control tumors and BLZ945 (Sotuletinib, 200 mg/kg; oral gavage; once daily for 21 days)-treated tumors with corresponding GFP expression demonstrating the twofold increase in control tumor volume. Middle panel is control lungs with grossly visible metastases (arrowheads). Bars: (black) 10 µm; (white) 5 mm.

  • Sotuletinib dihydrochloride